Medicare Enrolled
Dr. Pardeep Kumari, MD
Infectious Disease · Pensacola, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kumari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kumari
Dr. Pardeep Kumari is an infectious disease specialist in Pensacola, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kumari performed 198,805 Medicare services across 5,584 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kumari received a total of $2,948 from 28 pharmaceutical and/or device companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kumari is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in FL
$2,948 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 80464 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗198,805
Medicare services
Top 3% in FL for infectious disease
5,584
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,940 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 116,600 | $0 | $0 |
| Injection, meropenem, 100 mg | 16,957 | $0 | $10 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
8,399 | $1 | $10 |
| Vancomycin injection, 500 mg A 500 mg dose of vancomycin antibiotic is administered via injection. |
6,738 | $2 | $10 |
| Injection, cefepime hydrochloride, 500 mg | 5,760 | $1 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
4,877 | $49 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
4,539 | $64 | $225 |
| Ceftazidime injection, per 500 mg An injection of the antibiotic ceftazidime, billed for every 500 mg administered. |
4,314 | $1 | $10 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
3,573 | $0 | $10 |
| Refilling and maintenance of portable pump This service involves refilling and performing maintenance on a portable pump. |
3,366 | $97 | $200 |
| Cefazolin sodium injection, 500 mg An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body. |
2,746 | $1 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,740 | $101 | $175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
2,416 | $96 | $250 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
2,334 | $12 | $50 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
2,203 | $16 | $100 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
1,946 | $1 | $10 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
1,756 | $1 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
1,491 | $22 | $70 |
| Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,350 | $1 | $10 |
| Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 1,023 | $2 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
647 | $142 | $200 |
| Injection, furosemide, up to 20 mg | 624 | $0 | $10 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
601 | $137 | $300 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
544 | $79 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
311 | $105 | $275 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
295 | $99 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $133 | $200 |
| Wound tissue removal, each additional 20 sq cm This procedure involves the removal of tissue from a wound. It is billed for each additional 20 square centimeters of tissue removed beyond the initial amount. |
108 | $36 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $71 | $100 |
| New patient office visit, complex (60-74 min) | 72 | $177 | $225 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
71 | $10 | $120 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
57 | $120 | $250 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
43 | $84 | $225 |
| Strapping, unna boot | 31 | $62 | $100 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
23 | $107 | $275 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
17 | $144 | $300 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
14 | $25 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.5% high complexity
82.5% medium
8.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,948
Total received (2018-2024)
Avg $421/year across 7 years
Top 29% in FL for infectious disease
28
Companies
185
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,948 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$721
2023
$636
2022
$380
2021
$197
2020
$134
2019
$650
2018
$229
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Insmed, Inc.
$636
ViiV Healthcare Company
$370
Allergan Inc.
$259
Paratek Pharmaceuticals, Inc.
$232
ABBVIE INC.
$203
Merck Sharp & Dohme Corporation
$171
Merck Sharp & Dohme LLC
$139
Melinta Therapeutics, Inc.
$118
Smith+Nephew, Inc.
$105
Amgen Inc.
$101
Theratechnologies Inc.
$92
Janssen Biotech, Inc.
$66
MAYNE PHARMA INC.
$63
Ferring Pharmaceuticals Inc.
$48
HERAEUS MEDICAL, LLC.
$48
Urgo Medical North America, LLC
$43
TETRAPHASE PHARMACEUTICALS, INC.
$40
Averitas Pharma Inc.
$30
Octapharma USA, Inc.
$29
Solventum Corporation
$21
AIMMUNE THERAPEUTICS, INC.
$20
KCI USA, Inc.
$20
Melinta Therapeutics, LLC
$19
Organogenesis Inc.
$18
Allergan, Inc.
$16
Janssen Scientific Affairs, LLC
$14
Gilead Sciences, Inc.
$13
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 42.9% of total payments
Associated products mentioned in payments ›
ACTIV.A.C. · AVYCAZ · Arikayce · Baxdela · CABENUVA · COLLAGENASE SANTYL · DALVANCE · DIFICID · DOVATO · EGRIFTA · INVEGA SUSTENNA · ISENTRESS · JULUCA · KRYSTEXXA · NUZYRA · Orbactiv · PALACOS · PANZYGA · PIFELTRO · PREZCOBIX · Puraply · QUTENZA · REBYOTA · REGRANEX · Rezzayo · Symtuza · TEFLARO · TRIUMEQ · URGOK2 · V.A.C. VERAFLO · VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP · VOWST · Xerava
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Infectious diseases within 10 mi
11
Per 100K population
3.4
County median income
$65,715
Nearest hospital
HCA FLORIDA WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kumari is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kumari experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Kumari performed 116,600 daptomycin antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumari receive payments from pharmaceutical companies?
Yes. Dr. Kumari received a total of $2,948 from 28 companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumari's costs compare to other infectious diseases in Pensacola?
Dr. Kumari's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Pensacola
Browse infectious diseases in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in FL
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in FL
Which FL infectious diseases receive the most from drug and device companies.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology